Photo illustration of Wegovy and a weight scale. Wegovy is an injectable prescription weight loss … More medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images)
UCG/Universal Images Group via Getty Images
Hims & Hers Health (NYSE:HIMS) is set to release its earnings report on Monday, May 5, 2025. Historically, the stock has displayed considerable volatility around its earnings announcements. In the past five years, it has recorded a negative one-day return following earnings in 56% of instances, with a median negative return of -5.8% and a maximum negative return of -22.3%.
This upcoming earnings report is especially significant, as analysts project earnings per share of $0.23 on revenue of $538.4 million. These projections indicate nearly a two-fold increase compared to the earnings of $0.10 per share on revenue of $278.2 million reported in the same quarter last year. The company has been witnessing robust customer growth, and this trend is likely to continue.
For event-driven traders, grasping these historical patterns might provide a potential advantage, although the actual market reaction will largely hinge on how the reported results align with consensus estimates and overall market expectations. There are typically two strategies to consider: either positioning oneself prior to the earnings release based on historical probabilities, or evaluating the relationship between immediate and medium-term returns post-announcement to guide future trades.
From a fundamental viewpoint, Hims presently boasts a market capitalization of $7.7 billion. Its revenue over the trailing twelve months is $1.5 billion, and the company has shown operational profitability with $62 million in operating profits and a net income of $126 million.
That said, if you are looking for potential gains with less volatility than individual stocks, the Trefis High Quality portfolio offers an alternative – having outperformed the S&P 500 and generated returns exceeding 91% since its launch.
See earnings reaction history of all stocks
HIMS Stock Historical Odds Of Positive Post-Earnings Return
Some insights on one-day (1D) post-earnings returns:
- There are 16 earnings data points recorded over the last five years, with 7 positive and 9 negative one-day (1D) returns noted. In summary, positive 1D returns were recorded approximately 44% of the time.
- However, this percentage drops to 42% when considering data for the last 3 years rather than 5.
- Median of the 7 positive returns = 13%, with the median of the 9 negative returns = -5.8%
Additional information on observed 5-Day (5D) and 21-Day (21D) returns post earnings is summarized alongside the statistics in the table below.
HIMS 1D, 5D, and 21D Post Earnings Return
Trefis
HIMS Stock Correlation Between 1D, 5D, and 21D Historical Returns
A strategy with comparatively lower risk (though less useful if the correlation is weak) is to comprehend the correlation between short-term and medium-term returns post earnings, identify a pair that exhibits the highest correlation, and perform the necessary trade. For instance, if 1D and 5D show the strongest correlation, a trader may position themselves “long” for the next 5 days if the 1D post-earnings return is positive. Here is some correlation data based on 5-year and 3-year (more recent) history. Note that the correlation 1D_5D refers to the relationship between 1D post-earnings returns and subsequent 5D returns.
HIMS Correlation Between 1D, 5D and 21D Historical Returns
Trefis
Preserve & Grow Wealth With Risk-Focused Quality Portfolios
Discover more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (a combination of all 3, the S&P 500, S&P mid-cap, and Russell 2000), delivering strong returns to investors. Additionally, if you are seeking upside with a smoother experience than an individual stock like Hims & Hers Health, consider the High Quality portfolio, which has outperformed the S&P and achieved >91% returns since inception.
